Our timely recruitment of BPHunter to screen our COVID-19 cohort directly led to the identification of a novel and deleterious BP variant in the STAT2 gene from a patient with life-threatening COVID-19, which was immediately tested experimentally to demonstrate its biochemical consequences. This evidence concerns the gene STAT2 and COVID-19.